preparation and characterization of calibration standards for bone density determination by...
TRANSCRIPT
Preparation and characterization of calibration standards for bone densitydetermination by micro-computed tomography
Susanne Schweizer,*a Bodo Hattendorf,b Philipp Schneider,a Beat Aeschlimann,b Ludwig Gauckler,c
Ralph Mullera and Detlef Guntherb
Received 2nd March 2007, Accepted 23rd July 2007
First published as an Advance Article on the web 7th August 2007
DOI: 10.1039/b703220j
Phantoms for the calibration of local bone mineral densities by micro-computed tomography
(mCT), consisting of lithium tetraborate (Li2B4O7) with increasing concentrations of
hydroxyapatite [HAp, Ca10(PO4)6(OH)2] have been prepared and characterized for homogeneity.
Large-scale homogeneity and concentration of HAp in the phantom materials was determined
using laser ablation inductively coupled plasma mass spectrometry (LA-ICPMS), while
homogeneity on the micrometer scale was assessed through mCT. A series of standards was
prepared by fusion of pure HAp with Li2B4O7 in a concentration range between 0.12 and
0.74 g cm23. Furthermore, pressed and sintered pellets of pure HAp were prepared to extend
the calibration range towards densities of up to 3.05 g cm23. A linear calibration curve was
constructed using all individual standard materials and the slope of the curve was in good
agreement with calculated absorption coefficients at the effective energy of the mCT scanner.
Introduction
Micro-computed tomography (mCT) is an established techni-
que to assess three-dimensional bone micro-architecture of
cancellous and cortical bone.1 The amount of X-ray energy
that is absorbed by hydroxyapatite in a section of bone reflects
the bone mineral content. Bone mineral content divided by the
area or volume of the bone estimates the bone mineral density
(BMD). Laboratory studies have found a high correlation
between BMD and the force needed to break a bone.2–4 In
clinical practice, the availability of bone densitometry has
revolutionized the capacity to detect osteoporosis, since it
enables a determination of fracture risk and helps to select
patients for different treatment measures.5 However, little
headway has been made to accurately determine bone mineral
density (BMD) at the micrometer spatial resolution, due to the
fact that only very few suitable calibration standards are
available. In order to be useful for calibration of modern
mCT scanners, the calibration standards need to fulfil several
requirements: (a) their X-ray attenuation needs to reflect the
absorbance of bone minerals and they should cover a
representative range of mineral densities, and (b) they have
to be homogeneous at the spatial resolution of the scanner.
Since the main constituents of bone tissue are calcium and
phosphate, bound in the form of hydroxyapatite, both
criteria would be met if solid samples of hydroxyapatite were
available at variable densities and as homogenous phases at a
scale of ,10 mm.
Currently, solid phantom materials are in use that contain
the bone mineral hydroxyapatite for performing BMD
measurements in quantitative computed tomography (QCT)6,7
on millimeter to centimeter scales. Computed tomography
is widely used as a diagnostic tool in many medical
disciplines.8–11 Specifically, much research has been aimed
at the development of CT-based calibration phantoms to
mimic the attenuation profile of various tissue types.12–16
Commercially available bone phantom materials, such as the
epoxy resin-based SB3 introduced by White et al.17 contain-
ing 67% calcium carbonate, allow the accurate calibration
for cortical BMD. Several other phantoms have been designed
to quantify bone mineral density from CT images,12,18–24
and effects of temperature,25,26 imaging resolution27 and
radiation dosage27 have been studied in detail for such
phantoms. However, the concentration range covered and
the homogeneity of these phantoms make them suitable to
only a limited extent for mCT measurements. Owing to the
spatial resolution of mCT, assessment of the local bone mineral
content of individual bone struts, so-called trabeculae, is
possible. Thus, the mass attenuation coefficients that need to
be quantified by mCT in bones are significantly higher than the
averaged values obtained by QCT, reaching bone mineral
densities of up to 1.6 g cm23.28 However, higher phantom
material densities are desirable to perform mCT calibration, to
be able to also measure biomaterials (alone and after implanta-
tion in bone). These materials are very often ceramics, HAp
or tricalcium phosphate (TCP) based.29
Additionally, a suitable mCT reference material to calibrate
the scanner for BMD measurements has to mimic the
absorption properties of the underlying bone material.28,30,31
Increasing mass attenuation coefficients corresponding to
an exactly determined concentration of bone mineral have to
be attained. Also, the reference material has to be homogenous
on a micrometer scale such that the standard deviation of
the attenuation coefficient in a given area is reduced to a
minimum.
aInstitute for Biomedical Engineering, University and ETH Zurich,Switzerland. E-mail: [email protected] of Inorganic Chemistry, ETH Zurich, SwitzerlandcDepartment of Materials, Nonmetallic Inorganic Materials, ETHZurich, Switzerland
PAPER www.rsc.org/analyst | The Analyst
1040 | Analyst, 2007, 132, 1040–1045 This journal is � The Royal Society of Chemistry 2007
Publ
ishe
d on
07
Aug
ust 2
007.
Dow
nloa
ded
on 2
7/10
/201
4 05
:03:
16.
View Article Online / Journal Homepage / Table of Contents for this issue
So far, two commercially available mCT phantoms from
the CIRS (Computerized Imaging Reference Systems, Inc.,
Norfolk, USA) and Scanco (Scanco Medical, Bassersdorf,
Switzerland) companies and fluid phantoms containing
H2KPO4 are used for quantitative mineralization analysis of
bone specimens. However, they all have limited concentration
ranges of up to about 1 g cm23 HAp equivalents only. Higher
values of bone volume densities have to be extrapolated,
assuming an accurate correction of effects such as beam
hardening.32 In addition to their limited concentration range,
H2KPO4 phantoms have been shown to form air bubbles and
were therefore subjected to changing attenuation properties
over time. Replenishment and proper service at regular
intervals is needed for those phantoms.33
In this work we describe the preparation and characteriza-
tion of new phantom materials for the calibration of a mCT
scanner for BMD measurements. The materials cover a HAp
density range from 0.12 to 3.05 g cm23 and were prepared
using two different methods. One set of samples contained
HAp dissolved in a flux of lithium tetraborate (Li2B4O7), at
densities between 0.12 and 0.74 g cm23. Lithium tetraborate is
a traditionally used solid solvent for a wide range of minerals
and is commonly used for the production of homogenous
glassy samples for mineral bulk characterization in X-ray
fluorescence spectroscopy (XRF).34 It has a relatively low
X-ray absorption coefficient and low fluorescence yield and is
thus an ideal solvent for absorption measurements of a wide
range of materials. The mineral concentrations (or densities)
can be adjusted very easily and precisely by mixing known
weights of the flux and the mineral before the fusion.
A second set of standards was prepared by compaction of
HAp directly in a hydraulic press at different pressures. The
phantoms were measured in-house and the micro-scale
homogeneity was validated on a Scanco mCT scanner
(mCT 40, Scanco Medical, Bassersdorf, Switzerland). Large-
scale homogeneity and mineral contents were determined
using Laser Ablation Inductively Coupled Plasma Mass
Spectrometry (LA-ICPMS).
Experimental
Instrumentation
mCT measurements were carried out using a Scanco mCT
scanner (mCT 40, Scanco Medical, Bassersdorf, Switzerland)
using volume elements (voxels) of a size of 10 6 10 6 10 mm,
at an intensity of 160 mA. 1000 projections were acquired over
a range of 180u using an integration time of 200 ms. The
scanner was operated at a peak voltage of 50 kV and absorp-
tion was measured by applying a ten-frame averaging mode to
improve the signal-to-noise ratio. LA-ICPMS measurements
were performed using a GeoLas C laser ablation unit
(Microlas GmbH, Gottingen, Germany) in combination with
a 7500cs ICPMS unit (Agilent Technologies, Waldbronn,
Germany). Analyses were carried out by single spot analysis at
a spot size of 40 mm and a laser energy density of 7 J cm22. The
ablated material was transported into the ICPMS using helium
as carrier gas. Calibration of the instrument was performed
using the standard reference material NIST 610 (NIST,
Gaithersburg, USA). More detailed descriptions of the
operating principles of LA-ICPMS can be found, for example,
in Gunther and Hattendorf (2005),35 Durrant (1999)36 and
references therein.
Results and discussion
Hydroxyaptatite fused with lithium tetraborate
Low density HAp samples were prepared by fusion with
lithium tetraborate. Variable amounts of the HAp nano-
crystals (Berkeley Advanced Biomaterials Inc., USA) were
weighed on a precision balance (precision: ¡0.1 mg), followed
by addition of lithium tetraborate to a final weight of 6 g
(Table 1). After thorough mixing, the powders were trans-
ferred into platinum crucibles for fusion. The crucibles were
heated to a maximum temperature of 1300 uC for 10 min by
an oxygen/natural gas flame under constant agitation on
a commercial fusion machine (Autofluxer, Breitlander,
Germany) for 10 min. After dissolution was complete the melt
was poured into pre-heated Pt-moulds and allowed to cool.
Using this method, it was possible to prepare concentrations
of up to 30 wt% of HAp in lithium tetraborate. At higher
concentrations, HAp began to re-crystallize during cooling
and no homogeneous samples could be obtained. The samples
prepared by this method had a diameter of 32 mm and were
approximately 3 mm high. For further analysis by mCT, the
samples were broken into smaller pieces.
After preparation the fused beads were characterized for
large-scale homogeneity by spatially resolved analysis using an
established LA-ICPMS method.38 The samples were analyzed
at ten equally spaced positions between the center and the rim.
There is a slight depletion of HAp towards the inner parts of
the samples, which might have been a result of non-congruent
solidification of the melt. Nonetheless, the variation of the
HAp concentration across the entire sample was less than 10%
in all cases (Fig. 1). Blank values were below the instrumental
Table 1 Composition, measured mass attenuation and intra-measurement standard deviations (SD) for the different samples prepared withLi2B4O7
Sample HAp concentration (wt%) (¡1 SD)a HAp density/g cm23 (¡1 SD)b Linear attenuation/cm21 (¡1 SD)c
Blank ,0.02 ,0.0005 1.10 ¡ 0.034L05 4.96 ¡ 0.19 0.12 ¡ 0.057 1.46 ¡ 0.037L10 9.99 ¡ 0.28 0.23 ¡ 0.035 1.71 ¡ 0.048L20 19.97 ¡ 0.31 0.48 ¡ 0.018 2.33 ¡ 0.080L30 30.03 ¡ 0.95 0.74 ¡ 0.032 2.85 ¡ 0.097a Average concentrations and standard deviations for the entire samples according to LA-ICPMS analyses. b Combined uncertainty fromconcentration, mass and volume determinations.37 c Intra-scan standard deviation.
This journal is � The Royal Society of Chemistry 2007 Analyst, 2007, 132, 1040–1045 | 1041
Publ
ishe
d on
07
Aug
ust 2
007.
Dow
nloa
ded
on 2
7/10
/201
4 05
:03:
16.
View Article Online
detection limit (0.02 wt% of HAp). Apart from the major
constituents of HAp, several potential contaminants were
also analyzed. Most trace elements were present at or below
the instrumental detection limit, while magnesium [2 mg
(kg HAp)21], aluminium [0.2 mg (kg HAp)21], manganese
[0.015 mg (kg HAp)21], nickel [0.012 mg (kg HAp)21], copper
[0.008 mg (kg HAp)21], zinc [0.015 mg (kg HAp)21], strontium
[0.15 mg (kg HAp)21] and barium [0.01 mg (kg HAp)21] were
detectable at very low levels.
Density measurement of the lithium tetraborate pills
To assess the density of HAp in the pills, a small piece was
taken from an intermediate position of each pill, where the
concentration matched most closely the desired value, and
weighed precisely. The volume of the piece was determined by
scanning mCT and the density of HAp was calculated using the
volume and mass of the piece and the average concentration of
the HAp. The relative standard deviation (RSD) of the
volumetric measurements with mCT is 0.5%.37 According to
the variation of the HAp concentration across the individual
pills, the accuracy of the HAp densities is in the range of
5–10% relative.
Pure HAp pellets
Samples with higher densities of HAp cannot be produced by
the fusion method and were realized by compaction of the
raw material in a hydraulic press under different pressures
(Table 2). For compaction, a circular steel mould (10 mm
diameter) was filled with approximately 400 mg of HAp nano-
crystals and closed by a steel plunger, which transfers the
pressure to the material. The pressure was adjusted manually
and was kept constant for ca. 10 min.
One sample was additionally sintered in a temperature-
controlled electrical furnace (Nabertherm 1750 uC; Eurotherm
Fig. 1 Concentrations of HAp when fused with lithium tetraborate, at different locations across the samples L05–L30. Analyses were carried out
by LA-ICPMS. Error bars indicate one standard deviation of the individual results, based on counting statistics of the ICPMS data for calibration
and measurements.
Table 2 Conditions for preparation, densities, mass attenuation and corresponding intra-scan variations of the pure HAp pellets
Sample Press load/tons HAp density/g cm23 (¡1 SD)a Mass attenuation/cm21 (¡1 SD)b
Pressed powder samplesP05 0.5 1.24 ¡ 0.007 3.13 ¡ 0.16P10 1 1.41 ¡ 0.007 3.53 ¡ 0.19P20 2 1.61 ¡ 0.008 4.02 ¡ 0.20P30 3 1.77 ¡ 0.012 4.16 ¡ 0.21P50 5 1.95 ¡ 0.013 4.68 ¡ 0.23
Sintered powder sampleS50 5 3.05 ¡ 0.01c 7.19 ¡ 0.36
a Uncertainty calculated from readability of the balance and caliper. b Intra-scan standard deviation. c Relative uncertainty of the pycnometer.
1042 | Analyst, 2007, 132, 1040–1045 This journal is � The Royal Society of Chemistry 2007
Publ
ishe
d on
07
Aug
ust 2
007.
Dow
nloa
ded
on 2
7/10
/201
4 05
:03:
16.
View Article Online
controller, Nabertherm, Lilienthal, Germany) after pressing.
The furnace temperature was ramped from ambient to 800 uCat a rate of 2 uC min21 and kept constant for 30 min.
Subsequently the temperature was increased to 1300 uC at
5 uC min21 and held constant for another 180 min. After
sintering, the sample was allowed to cool to ambient
temperature at a rate of 2 uC min21 again.39 Table 2 lists the
conditions and resulting densities obtained for these samples.
Density measurement of the pure HAp pellets
The density of the sintered HAp pellet was determined
pycnometrically. The uncertainty of this determination is
¡0.001 g cm23 (see ref. 40).
The density of the pressed pellets was determined from their
geometrical volume (calculated from five individual measure-
ments of diameter and height) and the weight of the samples.
Micrometer-scale homogeneity characterization and
determination of mass attenuation using mCT
Micrometer-scale homogeneity of all samples was charac-
terized by scanning a sub-volume of 207 layers of each
material, at an intensity of 160 mA and using a voxel size of
10 6 10 6 10 mm. 1000 projections were acquired over a range
of 180u using an integration time of 200 ms. The samples were
placed inside a 20 mm cross-section polypropylene vial for
the measurement. Absorption data from a volume of 252 6252 6 100 voxels were used to calculate the linear attenuation
values and to estimate the homogeneity of the material.
Tables 1 and 2 list the linear attenuation coefficients and the
standard deviation of these measurements for the lithium
tetraborate samples and the pure HAp pellets, respectively.
Fig. 2 shows a typical distribution of the mass attenuation
coefficients for the sample P50 corresponding to a linear mass
attenuation coefficient of 4.68 ¡ 0.23 cm21. The variations in
the mass attenuation coefficients are typically 3% RSD for the
lithium tetraborate samples and 5% RSD for the pure pellets.
The distribution of the attenuation coefficients represents
the combined uncertainties arising from the homogeneity
of the material and the measurement uncertainty during signal
acquisition. It thus constitutes an upper limit for the estimate
of uncertainty of the homogeneity of the material. Averaging a
larger number of frames may reduce the overall uncertainty
but will also increase measurement times dramatically. A
compromise has to be made with respect to uncertainty and
analysis time. By visually inspecting sample homogeneity on a
micrometer scale, most phantoms also proved to be homo-
geneous at a resolution of 10 mm. In Fig. 3, representative
samples from the lithium tetraborate pills and the pressed pills
are shown. Only sample P05 shows variation of the attenua-
tion coefficient at the resolution of the scanner. This indicates
that the pressure applied is insufficient to compact the starting
material to below a range of 10 mm. At higher pressures and in
the fused material, however, the density of the material shows
an even distribution at the spatial resolution of the scanner.
Calibration of mass attenuation coefficients
Fig. 4 displays the relation between the average mass
attenuation values and the HAp density of the material for
the lithium tetraborate pills. Owing to absorption of the beam
by the fusion material, the calibration curve shows an offset.
This offset can be corrected by subtracting the absorption
caused by the mass fraction of lithium tetraborate present. A
linear fit to the data (Fig. 4, left) yields a correlation coefficient
(r2) of 0.9954 (0.9967 for the uncorrected data). A numerical
simulation of the absorption for the fused pills of the given
composition using the Photons software (Hasylab, Hamburg,
Germany) yields an X-ray energy of 26.6 keV, which is in
agreement with the effective energy of 26–27 keV for the mCT
scanner.41 It needs to be mentioned though that a quadratic fit
of the data resulted in a higher correlation coefficient (0.9997),
Fig. 2 Histogram of the mass attenuation data for the HAp pellet
P50. The solid line represents a fit to a Gaussian distribution.
Fig. 3 Representative areas (1 6 1 mm) for samples L10, L20, P05, and P20, scaled to the maximum intensity of the system. The pixel resolution
is 10 6 10 mm.
This journal is � The Royal Society of Chemistry 2007 Analyst, 2007, 132, 1040–1045 | 1043
Publ
ishe
d on
07
Aug
ust 2
007.
Dow
nloa
ded
on 2
7/10
/201
4 05
:03:
16.
View Article Online
indicating that secondary effects within the sample material,
such as beam hardening32 at higher HAp densities, were
present.
The mass attenuation of the pressed and sintered pellets of
HAp also shows a linear dependence on the HAp density
(Fig. 4, right). Nonetheless, the slope of this fit yields a
smaller slope, corresponding to a higher effective beam energy
(27–28 keV).
Fig. 5 shows a combined calibration graph for all samples
prepared in this study. Despite the different matrix composi-
tions, the correlation of the measured mass attenuation with
the HAp density is very high.
Selected regression data are listed in Table 3. The correlation
for the combined calibration curve is reasonably good, while
the slopes show variations of 12% RSD. According to the
regression statistics, the uncertainty of the results obtained
against this calibration are in the range of 10% RSD, as
indicated by the prediction interval in Fig. 5.
Conclusion
This study has shown that standards with mass densities
covering a wide range from 0.1 to 3 g cm23 can be prepared for
calibration of the X-ray absorption of hydroxyapatite. The
samples can be considered homogeneous on the scale of
current mCT scanners and thus allow a quantitative micro-
analytical characterization of bones. The new materials over-
come the uncertainty in a calibration, which is introduced by
extrapolating the calibration curve obtained from lower
density materials towards the actual mineral density values
found in trabeculae. The use of hydroxyapatite in the calibra-
tion standards is advantageous because its absorption of
X-rays is very close to that of bone mineral, which mitigates
measurement bias, induced by variation of the X-ray energies
and the corresponding changes in absorption cross-sections.
Furthermore, the materials contain only low concentrations
of other absorbing elements, which might additionally affect
the calibration.
The standards allow the calibration of mCT scanners for the
density of HAp with an accuracy of better than 10% relative,
which enables a spatially resolved quantitative characteriza-
tion of the bone mineral content.
Furthermore, the newly prepared phantoms are mechani-
cally stable, allowing them to be handled without special care.
The phantom weight did not significantly change over a two-
year period (differences below 1%). They can be cut and
polished when necessary to adjust them to individual sample
holders of mCT scanners.
Acknowledgements
Many thanks to Stefan Loher and the group of Professor Stark
at the Department for Chemistry and Applied Biosciences at
ETH Zurich for their help with the hydroxyapatite nano-
crystals. Many thanks also to Dr Elena Tervoort and Urs
Gonzenbach from the Department of Materials at the ETH
Fig. 4 Calibration graphs for mass attenuation versus HAp density in the fused pills (left) and pressed pellets (right). Error bars correspond to one
standard deviation of the linear attenuation and HAp densities respectively.
Fig. 5 Combined calibration curves for fused and pressed
HAp samples. Also given are the corresponding prediction intervals
(p = 95%).
Table 3 Regression data for the individual and combined calibrationcurves
Slope Intercept r2
Fused pillsa 2.81 0.053 0.9970Pressed pellets 2.24 0.33 0.9966All samples 2.31 0.20 0.9971a Corrected for absorption of the lithium tetraborate.
1044 | Analyst, 2007, 132, 1040–1045 This journal is � The Royal Society of Chemistry 2007
Publ
ishe
d on
07
Aug
ust 2
007.
Dow
nloa
ded
on 2
7/10
/201
4 05
:03:
16.
View Article Online
Zurich for their support with the sintering furnace and the
density determination of the HAp pills.
The research was funded by the Swiss National Science
Foundation (SNF) through the SNF Professorship in
Bioengineering (FP 620-58097.99).
References
1 P. Ruegsegger, B. Koller and R. Muller, Calcif. Tissue Int., 1996,58, 24–29.
2 A. C. Courtney, E. F. Wachtel, E. R. Myers and W. C. Hayes,J. Bone Joint Surg. Am., 1995, 77A, 387–395.
3 T. F. Lang, J. H. Keyak, M. W. Heitz, P. Augat, Y. Lu, A. Mathurand H. K. Genant, Bone, 1997, 21, 101–108.
4 J. C. Lotz and W. C. Hayes, J. Bone Joint Surg. Am., 1990, 72A,689–700.
5 P. Geusens and S. Boonen, J. Clin. Densitom., 1998, 1, 355–358.6 W. A. Kalender and C. Suess, Med. Phys., 1987, 14, 863–866.7 W. A. Kalender, D. Felsenberg, H. K. Genant, M. Fischer,
J. Dequeker and J. Reeve, Eur. J. Radiol., 1995, 20, 83–92.8 J. W. Byng, J. G. Mainprize and M. J. Yaffe, Phys. Med. Biol.,
1998, 43, 1367–1377.9 F. A. Jones, H. P. Wiedemann, P. B. Odonovan and J. K. Stoller,
Chest, 1989, 96, 779–784.10 J. A. Rumberger, B. H. Brundage, D. J. Rader and G. Kondos,
Mayo Clinic Proc., 1999, 74, 243–252.11 E. A. Zerhouni, J. F. Spivey, R. H. Morgan, F. P. Leo, F. P. Stitik
and S. S. Siegelman, J. Comput. Assisted Tomogr., 1982, 6,1075–1087.
12 D. R. White, Med. Phys., 1978, 5, 467–479.13 W. D. D’Souza, E. L. Madsen, O. Unal, K. K. Vigen, G. R. Frank
and B. R. Thomadsen, Med. Phys., 2001, 28, 688–700.14 P. Homolka, A. Gahleitner, M. Prokop and R. Nowotny, Phys.
Med. Biol., 2002, 47, 2907–2916.15 P. Homolka and R. Nowotny, Phys. Med. Biol., 2002, 47,
N47–N52.16 H. Q. Woodard and D. R. White, Br. J. Radiol., 1986, 59,
1209–1218.17 D. R. White, R. J. Martin and R. Darlison, Br. J. Radiol., 1977, 50,
814–821.18 P. M. Braillon, J. Clin. Densitom., 2002, 5, 259–266.
19 X. B. Chen and Y. M. Lam, Am. J. Phys. Anthropol., 1997, 103,557–560.
20 K. G. Faulkner, C. C. Gluer, M. Estilo and H. K. Genant, Calcif.Tissue Int., 1993, 52, 79–84.
21 M. M. Goodsitt, Bone Miner., 1992, 19, 145–158.22 M. M. Goodsitt, E. G. Christodoulou, S. C. Larson and
E. A. Kazerooni, Acad. Radiol., 2001, 8, 822–834.23 M. M. Goodsitt, R. F. Kilcoyne, R. A. Gutcheck, M. L.
Richardson and D. I. Rosenthal, Radiology, 1988, 167, 787–791.24 W. A. Kalender, E. Klotz and C. Suess, Radiology, 1987, 164,
419–423.25 P. Homolka, A. Gahleitner and R. Nowotny, Phys. Med. Biol.,
2002, 47, 2917–2923.26 K. E. Kellar and K. Briley-Saebo, Invest. Radiol., 1998, 33,
472–479.27 C. Suess, W. A. Kalender and J. M. Coman, Med. Phys., 1999, 26,
296–302.28 S. Nuzzo, F. Peyrin, E. Martin-Badosa, M. H. Lafage-Proust and
G. Boivin, IEEE Trans. Nucl. Sci., 2001, 48, 859–863.29 G. H. van Lenthe, H. Hagenmuller, M. Bohner, S. J. Hollister,
L. Meinel and R. Muller, Biomaterials, 2007, 28, 2479–2490.30 W. A. Kalender, Med. Phys., 1992, 19, 583–586.31 D. Pearson, S. A. Cawte and D. J. Green, Osteoporosis Int., 2002,
13, 948–954.32 R. A. Brooks and G. Di Chiro, Phys. Med. Biol., 1976, 21,
390–398.33 K. G. Faulkner, C. C. Gluer, S. Grampp and H. K. Genant,
Osteoporosis Int., 1993, 3, 36–42.34 E. Bauerwolf, W. Wegscheider, S. Posch, G. Knapp, H. Kolmer
and F. Panholzer, Talanta, 1993, 40, 9–15.35 D. Gunther and B. Hattendorf, TrAC, Trends Anal. Chem., 2005,
24, 255–265.36 S. F. Durrant, J. Anal. At. Spectrom., 1999, 14, 1385–1403.37 T. Kohler, M. Beyeler, D. Webster and R. Muller, Calcif. Tissue
Int., 2005, 77, 281–290.38 D. Gunther, A. von Quadt, R. Wirz, H. Cousin and V. J. Dietrich,
Microchim. Acta, 2001, 136, 101–107.39 N. Thangamani, K. Chinnakali and F. D. Gnanam, Ceram. Int.,
2002, 28, 355–362.40 Handbuch wagetechnische Applikationen, Sartorius AG, Weender
Landstraße 94-108, D-37075 Gottingen, Germany, 2004.41 Scanco Medical AG, Bassersdorf, Switzerland (http://www.scanco.
ch/; accessed 1 Aug 2007).
This journal is � The Royal Society of Chemistry 2007 Analyst, 2007, 132, 1040–1045 | 1045
Publ
ishe
d on
07
Aug
ust 2
007.
Dow
nloa
ded
on 2
7/10
/201
4 05
:03:
16.
View Article Online